DURECT to Participate in Susquehanna Financial Healthcare ... ( CUPERTINO Calif. Feb. 29 /- DUREC...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

DURECT to Participate in Susquehanna Financial Healthcare Conference

Date:2/29/2008

CUPERTINO, Calif., Feb. 29 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James Brown, President and Chief Executive Officer, will be presenting at the SIGnificant Investment Options in Healthcare conference hosted by Susquehanna Financial Group on Tuesday, March 4, 2008 at 2:45 p.m. EST. The conference is being held at the W Hotel, 541 Lexington Avenue, New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.

SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/9/2009)...., Nov. 9 - The U.S. Cen...ntly awarded the Pennsylvania Coalition Against Ra...o continue funding its National Sexual Violence Re...he NSVRC since 2000 to serve as the nation,s princ...g, and sharing information and resources about all...

(Date:11/9/2009)... Madeleines to the overbearing food critic in the ...ildhood at the aroma of stew, artists have long be...trong memories. Scientists at the Weizmann Institu...is of this connection. Their research appeared in ...te student Yaara Yeshurun, together with Profs. No...

(Date:11/9/2009)...those hurt are under 16, researchers say , ...juries have skyrocketed in the United States in re... 2007, a new study has found. , However, the t...ategory that includes whirlpools and spas -- remai...ut half of the injuries were caused by slips and f...

(Date:11/9/2009)..., Nov. 9 Renewal Laboratories anno... process to produce functional beverages with impo...al, nutritionally important supplements such as Co...ow be offered in appealing and refreshing drinks. ... of all natural drinks that can help maintain card...

(Date:11/9/2009)... On Tuesday November 10th, at 5:30 pm CS...g a lecture on Radiation Therapy Options for Mesot...ia teleconference, and via the mesocare.org websit...s) November 9, 2009 -- Mesothelioma lecture on T...org is sponsoring a lecture by Veronica Garza of M...

Breaking Medicine News(10 mins):Health News:CDC Awards Vital Prevention Funding to National Sexual Violence Resource Center 2 Health News:Sniffing out memories 2 Health News:Hot-Tub Injuries on the Rise 2 Health News:Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health 2

[0] CDC Awards Vital Prevention Funding to National Sexual Violence Resource Center [0] Sniffing out memories [0] Hot-Tub Injuries on the Rise [0] Renewal Laboratories(TM) Announces the First Omega3 Supplement Water for Cardiac Health [0] Radiation Therapy Options for Mesothelioma Patients Sponsored by MesoCare.org

...vival increase according to stage of disease, a ne... issue of CANCER, a peer-reviewed journal of the A...f survival data demonstrates that within each stag...inical factors the racial disparities in survival ...

...ditorial, to be published in the international jou...sevierhealth.com/journals/joca/ ), published by El...recommended that coxibs and nonsteroidal anti-infl...an international workshop organized by the Osteoar...

...en a routine visit to the family doctor includes a...ing Alzheimer’s disease (AD). If the test returns ...ns that might begin to gum up memory and thought i...hers at Mayo Clinic’s campus in Jacksonville aims ...

...ts who do not respond to traditional therapy can b...l transplant, according to an Indiana University S...he New England Journal of Medicine. About 90 p...tment of this disease by Lawrence Einhorn, M.D., a...

...eached 'epidemic' levels for the second time in th...ay said. The Ministry of Health said 381 ...the 'epidemic threshold' of 378 cases per week. ... ministry said. Singapore experienced its ...

...rth of the first baby to be produced from an egg, ... and defrosted for later use. The news pr...failure or who cannot be administered drugs that h...ductive Centre in Montreal. The baby's mother has ...

Survival differences by race most apparent in advanced stages of breast cancer Using coxibs and NSAIDs to treat osteoarthritis A new century of Alzheimer's disease research Advanced therapy offers cure for relapsed cancer patient Singapore Dengue Cases Return to Epidemic Level First Baby Born from Eggs Matured and Frozen in the Lab

(Date:11/9/2009)... 9 Bend Research Inc., a company,w...nnovative pharmaceutical,technologies to help clie...nical problems, announced today that it has entere... Incorporated, a global biotechnology company,head...s new collaboration, Vertex will utilize Bend,s fo...

(Date:11/8/2009)...e of Health Care Reform Bill ,, Critical legi...e for all Americans ,, BOISE, Idaho, Nov. 7 ... House of Representatives passed critical health c...are for seniors and end discrimination by insuranc...of affordable health coverage. ,, The Afforda...

(Date:11/6/2009)...ire-FirstCall/ -- Recession in domestic and intern...ied Healthcare Products in the first quarter of fi...les declines pushed Allied into a loss for the qua...,000, or negative 9 cents per share, compared to a... 3 cents per share. ,, Sales fell about 21 per...

Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2 Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3 AARP Idaho Key Vote News Alert 2 AARP Idaho Key Vote News Alert 3 Recession Continues to Depress Sales at Allied Healthcare Products 2 Recession Continues to Depress Sales at Allied Healthcare Products 3 Recession Continues to Depress Sales at Allied Healthcare Products 4 Recession Continues to Depress Sales at Allied Healthcare Products 5 Recession Continues to Depress Sales at Allied Healthcare Products 6 Smart for Life 28TM 29 Featured in Womans World Magazine 51752 1 Smart for Life 28TM 29 Featured in Womans World Magazine 51752 2 Oncolytics Biotech 28R 29 Inc Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting 13038 1 Oncolytics Biotech 28R 29 Inc Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting 13038 2 Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 1 Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 2 Cellular Dynamics International In Licenses Key Patent Portfolio for Using Stem Cell Derived Cells in Drug Testing 13037 3

[0] Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration [0] AARP Idaho Key Vote News Alert [0] Recession Continues to Depress Sales at Allied Healthcare Products

...lts at 2007 American Association for,Cancer Resear...wswire-FirstCall/ -- Cleveland,BioLabs, Inc. , ann... CBLB502,s efficacy as a mitigator of both,gastroi...d,production) radiation-induced damage in non-huma..., Andrei Gudkov, Ph.D, D. Sci.,will present resul...

...ESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline (LSE and ...ay announced data from Study 767905/014 and,provid...or,alvimopan (Entereg/Entrareg(R))., Study 014, a ...h) study, was designed to evaluate the long-term s...aily in patients taking,opioids for chronic non-ca...

Other Medicine Technology:Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 2 Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 3 GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2 GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3 GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4 GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5 GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6 GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7

Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg)

...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...

Medicine Products:

Allergen, Fungi & Molds,Curvulariaspeciferia Allergen, Fungi & Molds,Candida Albicans IgG Allergen, Fungi & Molds, Aureobasidium pullulans IgG Allergen, Fungi & Molds, Alternaria tenuis IgG

DURECT to Participate in Susquehanna Financial Healthcare ...( CUPERTINO Calif. Feb. 29 /- DUREC...),Health